Fisiologia e fisiopatologia endocrina

This book presents an up-to-date survey of the current scientific understanding of obesity and the metabolic syndrome, as well as an overview of the most significant changes to the field over the past 30 years. The book defines obesity and realistically assesses its prevalence. It further examines and evaluates the success of traditional cognitive behavioral treatment. This volume is a thorough reference for obesity and the metabolic syndrome.

The new 5th version of this leading reference presents a complete and up-to-date review and analysis of all aspects of endocrinology, diabetes, and bone metabolism - both in print and online. Readers will also find state-of-the-art information on genetics, proteinomics, and hormone signaling, and coverage the field's hottest topics, in nearly 20 new chapters. Joined by an international team of leading experts - many new to this edition - Drs. Jameson and DeGroot provide guidance that integrates the basic science of endocrinology with clinical medicine and the practical management of endocrine disorders. A clinical focus emphasizes diagnosis and therapy, and over 1,400 illustrations clarify complex concepts. The changes with the field...meets all of your reference needs...and never goes out of date.

After half a century of doubt and debate, dyslipidemia has at last been accepted by cardiologists and the medical community at large as a major, treatable cause of atherosclerotic cardiovascular disease. A number of guidelines have been issued on the management of dyslipidemia in preventing coronary heart disease. A working knowledge of the various types of dyslipidemia and their treatment is highly relevant to modern medicine, with its accent on prevention. This book, written by a general practitioner, an epidemiologist, and a lipidologist, provides a broad and up-to-date perspective of dyslipidemia and is chiefly intended for use in primary care. It details normal lipid metabolism, describes the genetic and acquired causes of dyslipidemia and reviews the evidence that the latter is a risk factor for vascular disease. Most of the book, however, is devoted to the practicalities of screening, risk assessment and management of dyslipidemia in everyday clinical practice, including chapters summarizing current guidelines, the importance of diet and the role of lipid-lowering drugs. Cardiologists, general practitioners and pharmacists will find this volume indispensable.

Endocrine Pathophysiology offers a comprehensive introduction to diseases of the endocrine system. Rather than providing an overwhelming amount of content on one subject, this book serves as a bridge between basic endocrine physiology and endocrine disorders. Included in the text are case studies covering a variety of endocrine disorders in both inpatient and outpatient settings. With the changes in many medical school curriculums to a clinically-based curriculum, this book provides a cutting-edge approach to endocrine pathophysiology.

The first comprehensive text on dyslipidemia from a major academic institution, this book covers all aspects of dyslipidemia as it relates to human disease, including coronary artery disease, cerebrovascular disease, peripheral vascular disease, and pancreatitis. The material is presented in a clinician-friendly format and includes references for additional reading. Reflecting current guidelines from the National Cholesterol Education Program, the book explains why, when, and how to treat dyslipidemia. Coverage includes dietary treatment, drug treatment, and recommendations for special populations such as patients with coronary heart disease, patients at high risk for coronary heart disease, patients with diabetes, women, older adults, young adults, and racial and ethnic groups.